Literature DB >> 33204056

Response to "Letter to the Editor: Coronavirus disease 2019 (COVID-19) markedly increased mortality in patients with hip fracture: A systematic review and meta-analysis".

Michael Anthonius Lim1, Raymond Pranata1.   

Abstract

Entities:  

Year:  2020        PMID: 33204056      PMCID: PMC7661944          DOI: 10.1016/j.jcot.2020.11.008

Source DB:  PubMed          Journal:  J Clin Orthop Trauma        ISSN: 0976-5662


× No keyword cloud information.
The pooled prevalence of COVID-19 of 9% [95% CI: 7%–11%] in the manuscript is referring to the fixed effect, while the prevalence of COVID-19 of 16% 995% CI: 8%–24%) is referring to the random effect. The use of random effect is more accurate than fixed effect. Regarding the prevalence of 13.8% (76 COVID-19 positive patients from a pooled cohort of 552 hip fracture patients), this figure represents a rough estimate of prevalence. However, in a meta-analysis, data were assigned a weighted per study rather than simply divide the number of positive cases per total cohort. Regarding the rate of COVID-19 by sex, male subjects were obviously shown to have greater mortality rate than female subjects. Being females increases their risk of developing osteoporosis, which is one of the risk factor that may explain the mechanism of fracture. In contrary, the male population may require high-energy trauma or the presence of pathologies to suffer a fracture, therefore they may possess comorbidities or accompanying pathologies that put them at increased risk of death. We did not perform sex-related meta-analysis, considering that males were clearly have a higher prevalence and mortality rate than females. Additionally, we did not have individual patient data and the number of studies was too small for the study level to conduct meta regression.
  3 in total

1.  Meta-analysis and metaregression of risk factors associated with mortality in hip fracture patients during the COVID-19 pandemic.

Authors:  Firas J Raheman; Djamila M Rojoa; Jvalant Nayan Parekh; Reshid Berber; Robert Ashford
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

2.  Mortality among hip fracture patients infected with COVID-19 perioperatively.

Authors:  Johannes Fessler; Thomas Jacobsen; Jes Bruun Lauritzen; Henrik Løvendahl Jørgensen
Journal:  Eur J Trauma Emerg Surg       Date:  2021-03-11       Impact factor: 3.693

3.  The prevalence, mortality, and associated risk factors for developing COVID-19 in hip fracture patients: a systematic review and meta-analysis.

Authors:  Nicholas D Clement; Nathan Ng; Cameron J Simpson; Robyn F L Patton; Andrew James Hall; A Hamish R W Simpson; Andrew D Duckworth
Journal:  Bone Joint Res       Date:  2020-12       Impact factor: 4.410

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.